Based on these results and considering the AFP‐producing nature and potential germ cell tumor differentiation, bleomycin, etoposide, and cisplatin (BEP) therapy was initiated 12 months after initial treatment, following the protocol for germ cell tumors (GCTs). This evidence concerns the gene AFP and germ cell tumor.